China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) — Cash Flow Reinvestment Rate
China Resources Sanjiu Medical & Pharmaceutical Co Ltd (000999) has a Cash Flow Reinvestment Rate of 2.38x as of September 2025, reinvesting CN¥302.02 Million (capex CN¥302.02 Million ) from operating cash flow of CN¥126.71 Million. See 000999 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Sanjiu Medical & Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (1999–2024)
Historical reinvestment intensity for China Resources Sanjiu Medical & Pharmaceutical Co Ltd across 25 annual periods. For the full cash flow conversion analysis, see how efficiently does China Resources Sanjiu Medical & Pharmac generate cash.
Annual Cash Flow Reinvestment Rate for China Resources Sanjiu Medical & Pharmaceutical Co Ltd (1999–2024)
Year-by-year capital reinvestment analysis for China Resources Sanjiu Medical & Pharmaceutical Co Ltd. See 000999 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.24x | CN¥1.04 Billion | CN¥4.40 Billion | CN¥790.07 Million | ▼ -39.9% |
| 2023 | 0.39x | CN¥1.65 Billion | CN¥4.22 Billion | CN¥857.21 Million | ▼ -65.7% |
| 2022 | 1.14x | CN¥3.43 Billion | CN¥3.01 Billion | CN¥951.57 Million | ▲ +22.6% |
| 2021 | 0.93x | CN¥1.74 Billion | CN¥1.87 Billion | CN¥870.80 Million | ▲ +47.4% |
| 2020 | 0.63x | CN¥1.40 Billion | CN¥2.22 Billion | CN¥621.82 Million | ▲ +89.3% |
| 2019 | 0.33x | CN¥657.49 Million | CN¥1.97 Billion | CN¥535.97 Million | ▼ -22.3% |
| 2018 | 0.43x | CN¥820.07 Million | CN¥1.91 Billion | CN¥600.36 Million | ▼ -13.6% |
| 2017 | 0.50x | CN¥774.84 Million | CN¥1.56 Billion | CN¥374.74 Million | ▼ -56.2% |
| 2016 | 1.13x | CN¥1.58 Billion | CN¥1.39 Billion | CN¥354.33 Million | ▲ +58.3% |
| 2015 | 0.72x | CN¥902.16 Million | CN¥1.26 Billion | CN¥330.65 Million | ▲ +148.6% |
| 2014 | 0.29x | CN¥341.22 Million | CN¥1.18 Billion | CN¥341.22 Million | ▲ +19.1% |
| 2013 | 0.24x | CN¥354.89 Million | CN¥1.47 Billion | CN¥354.89 Million | ▼ -41.9% |
| 2012 | 0.42x | CN¥504.52 Million | CN¥1.21 Billion | CN¥504.52 Million | ▼ -3.0% |
| 2011 | 0.43x | CN¥409.79 Million | CN¥954.90 Million | CN¥409.79 Million | ▲ +34.8% |
| 2010 | 0.32x | CN¥270.00 Million | CN¥848.28 Million | CN¥270.00 Million | ▲ +41.1% |
| 2009 | 0.23x | CN¥192.93 Million | CN¥855.05 Million | CN¥192.93 Million | ▼ -79.1% |
| 2008 | 1.08x | CN¥1.20 Billion | CN¥1.12 Billion | CN¥1.20 Billion | ▲ +187.7% |
| 2007 | 0.37x | CN¥226.78 Million | CN¥605.30 Million | CN¥226.78 Million | ▲ +17.4% |
| 2006 | 0.32x | CN¥135.81 Million | CN¥425.51 Million | CN¥135.81 Million | ▼ -80.4% |
| 2005 | 1.63x | CN¥37.14 Million | CN¥22.83 Million | CN¥37.14 Million | ▼ -66.4% |
| 2003 | 4.84x | CN¥135.88 Million | CN¥28.09 Million | CN¥135.88 Million | ▲ +1289.6% |
| 2002 | 0.35x | CN¥172.67 Million | CN¥496.12 Million | CN¥172.67 Million | ▼ -55.1% |
| 2001 | 0.77x | CN¥118.83 Million | CN¥153.44 Million | CN¥118.83 Million | ▲ +21.2% |
| 2000 | 0.64x | CN¥170.58 Million | CN¥266.86 Million | CN¥170.58 Million | ▲ +5.0% |
| 1999 | 0.61x | CN¥73.43 Million | CN¥120.63 Million | CN¥73.43 Million | — |